65 results
Page 3 of 4
8-K
EX-99
mbt2ydp snq8
12 Nov 19
Cue Biopharma Reports Third Quarter 2019 Financial Results
4:05pm
8-K
EX-1.1
0d1227 lvzin9anqep9
5 Jun 19
Entry into a Material Definitive Agreement
8:55am
424B5
38d5 pngatwh13xw8lpw
5 Jun 19
Prospectus supplement for primary offering
8:49am
424B3
kgom5n
8 Feb 19
Prospectus supplement
4:16pm
S-3
c3ulozvorc4xz75dhjfy
4 Jan 19
Shelf registration
5:02pm
8-K/A
EX-10.1
0qnbeguysr b8zwv
26 Dec 18
Cue Biopharma and LG Chem Life Sciences Announce WT1
4:31pm
8-K/A
EX-99.1
e30g7ck4bpyn y0d
26 Dec 18
Cue Biopharma and LG Chem Life Sciences Announce WT1
4:31pm
8-K/A
EX-10.1
1em8s ev8tri11
13 Nov 18
Entry into a Material Definitive Agreement
4:22pm
8-K
EX-99.1
i1z1dhb
8 Nov 18
Entry into a Material Definitive Agreement
8:13am
424B3
fgg8mq
23 Jul 18
Prospectus supplement
4:44pm
8-K
EX-99
k77llg s2
12 Jul 18
Cue Biopharma Produces Immuno-STATTM Biologic Candidate for Treatment of Autoimmune Disease Under Collaboration and License Agreement with Merck
8:40am
8-K
EX-10.1
pp3d4ie0nb9ht6mf
20 Jun 18
Entry into a Material Definitive Agreement
12:00am